Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E62.99 EPS (ttm)1.68 Insider Own11.30% Shs Outstand1.05B Perf Week3.30%
Market Cap111.26B Forward P/E18.44 EPS next Y5.74 Insider Trans-2.28% Shs Float1.05B Perf Month19.61%
Income1.77B PEG5.21 EPS next Q1.36 Inst Own79.20% Short Float1.43% Perf Quarter29.32%
Sales23.87B P/S4.66 EPS this Y-37.00% Inst Trans-0.29% Short Ratio4.05 Perf Half Y36.45%
Book/sh11.22 P/B9.43 EPS next Y4.90% ROA-0.30% Target Price97.13 Perf Year37.30%
Cash/sh6.57 P/C16.10 EPS next 5Y12.10% ROE-1.10% 52W Range73.69 - 105.92 Perf YTD25.29%
Dividend2.25 P/FCF53.41 EPS past 5Y-15.00% ROI6.60% 52W High-0.09% Beta0.24
Dividend %2.13% Quick Ratio1.10 Sales past 5Y0.20% Gross Margin72.90% 52W Low43.60% ATR1.56
Employees40655 Current Ratio1.40 Sales Q/Q9.10% Oper. Margin9.10% RSI (14)88.40 Volatility1.43% 1.80%
OptionableYes Debt/Eq1.06 EPS Q/Q-126.50% Profit Margin-0.60% Rel Volume0.75 Prev Close105.55
ShortableYes LT Debt/Eq0.79 EarningsJul 24 BMO Payout- Avg Volume3.70M Price105.82
Recom2.30 SMA206.10% SMA5014.93% SMA20025.46% Volume2,754,874 Change0.26%
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-27-16Upgrade Goldman Neutral → Buy
Sep-08-16Upgrade JP Morgan Neutral → Overweight
May-02-16Reiterated Leerink Partners Outperform $96 → $101
Apr-06-16Initiated Societe Generale Hold $78
Dec-28-15Reiterated Leerink Partners Outperform $93 → $95
Dec-07-15Upgrade Deutsche Bank Hold → Buy $85 → $99
Dec-01-15Upgrade Barclays Equal Weight → Overweight $75 → $95
Aug-20-18 01:05PM  Drugmakers Extend Summer Rally as Markets Regain Footing Bloomberg
Aug-17-18 05:41PM  Should you trade or fade this week's biggest winners? CNBC Videos
10:23AM  Lilly (LLY) Hits 52-Week High, Can the Run Continue? Zacks
08:15AM  The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns Benzinga
Aug-16-18 02:00PM  Eli Lilly's Overbought Stock Poised to Fall 15% Investopedia
Aug-15-18 05:39PM  [$$] Karuna Appoints Steven Paul as CEO The Wall Street Journal
Aug-14-18 09:25PM  Elanco Animal Health Announces Pricing of $2.0 Billion of Senior Notes PR Newswire
Aug-13-18 09:48AM  Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings Zacks
Aug-10-18 08:08AM  Eli Lilly Stock History Motley Fool
Aug-09-18 10:04AM  Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates Zacks
Aug-08-18 09:15AM  Is Eli Lilly (LLY) a Great Dividend Play? Zacks
Aug-07-18 01:00PM  Why Health Care Stocks Are Outshining The Techs Investopedia
09:50AM  Q2 Earnings Drive Pharma ETFs Higher Zacks
Aug-06-18 04:08PM  Does Bausch Face A Reckoning? 5 Key Issues To Look For In Its Earnings Investor's Business Daily
Aug-03-18 12:39PM  Eli Lilly Breaks Out of a Large Consolidation Pattern, Further Gains Ahead TheStreet.com
07:52AM  The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings Benzinga
07:15AM  Jim Cramer: 4 Pet-Related Stocks That Are Top Dog TheStreet.com
Aug-02-18 07:32PM  Drugmaker Lilly's Elanco animal health unit files for IPO Reuters
06:19PM  Drugmaker Lilly's Elanco animal health unit files for IPO Reuters
05:51PM  Eli Lilly's Animal-Health Business Files for Initial Public Offering Bloomberg
05:40PM  Elanco Animal Health Files IPO Registration Statement PR Newswire
05:24PM  Diabetes Superpower Eli Lilly's Results Motley Fool
Aug-01-18 05:24PM  Here's What's Going On at Eli Lilly and GlaxoSmithKline Motley Fool
04:12PM  Why The 'Heat Wave' For U.S. Pharma Could Continue This Month Investor's Business Daily
02:18PM  Healthcare Bulls Are Feeling Great After Earnings TheStreet.com
09:00AM  Lilly Diabetes Solution Center Now Open to Help People with Insulin Affordability PR Newswire
12:00AM  [$$] Trump is losing the war on drug prices Financial Times
Jul-31-18 04:00PM  Incyte (INCY) Earnings Miss, Revenues Beat Estimates in Q2 Zacks
Jul-30-18 06:45AM  Lilly Announces Extension of Cancer Research Collaboration with Dana-Farber Cancer Institute PR Newswire
Jul-29-18 05:29PM  Barron's Picks And Pans: Amazon, Eli Lilly, Fiat Chrysler And More Benzinga
Jul-28-18 09:15AM  Tech Turmoil Ruins GDP Party Zacks
Jul-27-18 08:27PM  [$$] Rosy Outlook for Lilly Barrons.com
11:43AM  Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV's Elagolix Gets FDA Nod Zacks
11:15AM  Merck (MRK) Q2 Earnings & Sales Top on Keytruda Strength Zacks
08:00AM  New Research: Key Drivers of Growth for ICU Medical, A. Schulman, Verso, Eli Lilly, Spectrum Pharmaceuticals, and Intuit Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jul-26-18 11:30AM  Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan Zacks
10:20AM  Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, '18 View Up Zacks
07:55AM  ABBV, MRK Q2 Earnings on Jul 27: Here are the Key Predictions Zacks
07:30AM  Initiating Free Research Reports on Pfizer and Three Other Drug Makers Equities ACCESSWIRE
07:00AM  FOCUS-Amgen's new migraine drug hits insurance hurdles Reuters
01:00AM  FOCUS-Amgen's new migraine drug hits insurance hurdles Reuters
Jul-25-18 12:24PM  AbbVie Secures FDA Approval for Endometriosis Drug Elagolix Zacks
10:49AM  Company News For Jul 25, 2018 Zacks
10:27AM  Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More Zacks
08:00AM  Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Eli Lilly and Company ACCESSWIRE
Jul-24-18 11:40PM  Earnings Boost U.S. Stocks The Wall Street Journal +5.03%
08:06PM  [$$] Eli Lilly to Offer Minority Stake in Animal-Health Business The Wall Street Journal
05:13PM  Edited Transcript of LLY earnings conference call or presentation 24-Jul-18 1:00pm GMT Thomson Reuters StreetEvents
04:31PM  S&P reaches highest level since February as Alphabet shares soar Reuters
01:58PM  [$$] Eli Lilly to Offer Minority Stake in Animal-Health Business The Wall Street Journal
12:46PM  Lilly plans Elanco IPO, posts quarterly profit above estimates Reuters
12:46PM  Lilly plans Elanco IPO, posts quarterly profit above estimates Reuters
12:35PM  Eli Lilly's Good Quarter Masks Deeper Risks Bloomberg
12:00PM  AstraZeneca Sells Atacand's European Rights to Cheplapharm Zacks
11:36AM  Biogen, Eli Lilly earnings beats push industry stocks up MarketWatch
11:35AM  Stocks - Alphabet, Harley-Davidson, Verizon Gain in Pre-market; Whirlpool Tanks Investing.com
10:53AM  Eli Lilly and Company -- Moody's: Lilly's planned separation of Elanco is credit negative Moody's
10:36AM  Lilly (LLY) Tops Q2 Earnings, Chooses IPO Path for Elanco Zacks
10:25AM  Biotech ETFs surge, supported by strong results from Biogen and Eli Lilly MarketWatch
10:08AM  Eli Lilly (LLY) Tops Q2 Earnings and Revenue Estimates Zacks
10:06AM  Alphabet Isn't the Only Company With an Earnings Blowout - Here's the Rundown TheStreet.com
09:41AM  Drugmaker Lilly plans IPO for part of animal health business Associated Press
09:22AM  Stocks to Watch: Alphabet, Verizon, Whirlpool, Harley-Davidson, 3M, Lockheed Martin, Eli Lilly The Wall Street Journal
09:14AM  Corrected: Eli Lilly to take animal health unit public Reuters
09:08AM  Eli Lilly Shares Climb on Earnings Beat TheStreet.com
08:22AM  Eli Lilly to take animal health unit public Reuters
08:10AM  Eli Lilly Won't Raise Drug Prices This Year, CEO Says Bloomberg Video
08:09AM  Eli Lilly Won't Raise Drug Prices This Year, CEO Says Bloomberg
08:00AM  Eli Lilly (LLY) Tops Q2 Earnings & Sales, Ups 2018 View Zacks
07:52AM  Stocks making the biggest moves premarket: MMM, UTX, VZ, LLY & more CNBC
07:32AM  Eli Lilly tops 2Q earnings, guidance expectations Associated Press
07:14AM  Eli Lilly CEO: We're growing based on the back of our new... CNBC Videos
07:06AM  Eli Lilly spins off animal health unit, second quarter beats Reuters
07:02AM  Eli Lilly shares surge after animal health IPO, earnings beat CNBC
06:50AM  Eli Lilly's stock jumps after earnings beat, potential IPO of Elanco Animal Health MarketWatch
06:25AM  Lilly Delivers Strong Second-Quarter 2018 Results, Revises EPS Guidance PR Newswire
06:24AM  Eli Lilly plans initial public offering of its Elanco animal health unit CNBC
06:20AM  Lilly to Separate Elanco Animal Health with Initial Public Offering PR Newswire
05:13AM  Dow futures are set to rise following strong earnings from Google parent Alphabet CNBC
Jul-23-18 03:52PM  Eli Lilly's Q2 Earnings Preview Benzinga
Jul-22-18 10:47AM  Here's Why Big Pharma Loves This Plan to Lower Drug Prices Motley Fool
Jul-21-18 11:29PM  [$$] Pakistan election, Juncker visits Trump, US tech earnings Financial Times
Jul-20-18 11:35AM  Lilly (LLY) Issues Update on Diabetes Drug Trulicity Label Zacks
09:30AM  Highlights from Lilly's Alzheimer's Disease Pipeline at the Alzheimer's Association International Conference® 2018 (AAIC® 2018) PR Newswire
08:59AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals Zacks
08:17AM  Better Buy: Eli Lilly and Company vs. Merck & Co. Motley Fool
07:31AM  Eli Lilly Scores a Win in Diabetes Motley Fool
Jul-19-18 06:30PM  Study Published in The Lancet Shows Benefit of Baricitinib 4 mg for the Treatment of Systemic Lupus Erythematosus (SLE) PR Newswire
09:50AM  LLY vs. NVO: Which Stock Is the Better Value Option? Zacks
09:45AM  LLY vs. NVO: Which Stock Is the Better Value Option? Zacks
09:38AM  Can Eli Lilly (LLY) Keep the Earnings Streak Alive in Q2? Zacks
09:28AM  Pfizer & Lilly's Pain Candidate Succeeds in Phase III Study Zacks
08:00AM  Boehringer Ingelheim and Lilly announce Tradjenta's CARMELINA® cardiovascular outcome trial meets primary endpoint PR Newswire
07:43AM  The Zacks Analyst Blog Highlights: Netflix, Eli Lilly, BNY, TJX and Raytheon Zacks
06:45AM  Lilly's Once-Weekly Trulicity® (dulaglutide) Label Updated to Include Data Showing Benefits for Adults with Type 2 Diabetes and Chronic Kidney Disease PR Newswire
Jul-18-18 03:26PM  Pfizer, Eli Lilly non-opioid pain drug nears finish line MarketWatch
03:02PM  Top Analyst Reports for Netflix, Eli Lilly & BNY Mellon Zacks
08:51AM  Pfizer-Lilly pain drug meets late-stage trial goals Reuters
08:49AM  Pfizer-Lilly pain drug meets late-stage trial goals Reuters
06:57AM  Pfizer-Lilly pain drug found effective in late-stage study Reuters
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; and Nektar Therapeutics, as well as has strategic collaboration with Sigilon Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
LILLY ENDOWMENT INC10% OwnerApr 25Sale80.85180,00014,553,614122,895,804Apr 26 12:38 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 16Sale80.0817,3791,391,71028,273Apr 17 03:29 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 13Sale80.145,165413,92345,652Apr 17 03:29 PM
Smiley Joshua LSVP and CFOMar 16Sale79.203,000237,60020,029Mar 20 12:06 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale76.5086065,7901,637Mar 05 03:30 PM
Zakrowski Donald AChief Accounting OfficerFeb 21Sale77.5587667,9342,472Feb 23 05:42 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048048Feb 21 10:28 AM
Zakrowski Donald AChief Accounting OfficerFeb 05Sale81.0990072,9814,130Feb 05 06:39 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 05Sale81.129,625780,780133,201Feb 05 06:37 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 01Option Exercise0.0021,3260152,120Feb 05 06:37 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0015,993065,357Feb 05 06:33 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0021,3260140,809Feb 05 06:31 PM
Mahony SusanSVP & Pres., Lilly OncologyFeb 01Option Exercise0.0021,326060,350Feb 05 06:24 PM
Lundberg Jan MEVP,Science&Tech and Pres. LRLFeb 01Option Exercise0.0036,2520214,295Feb 05 06:21 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0024,5240102,738Feb 05 06:19 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0017,0600107,820Feb 05 06:15 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0021,3260147,980Feb 05 06:12 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.006,398022,107Feb 05 06:09 PM
LILLY ENDOWMENT INC10% OwnerDec 13Sale88.20200,00017,639,176123,075,804Dec 14 11:26 AM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthDec 11Sale86.4612,5001,080,750124,522Dec 13 03:01 PM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 04Sale86.003,532303,75240,048Dec 05 05:35 PM
Mahony SusanSVP & Pres., Lilly OncologyDec 04Sale86.1836,5853,152,89554,885Dec 05 05:32 PM
Zakrowski Donald AChief Accounting OfficerDec 03Option Exercise0.003,28104,167Dec 05 05:48 PM
Fry Stephen FSVP, HR & DiversityDec 03Option Exercise0.007,557086,501Dec 05 05:46 PM
Ricks David APresident & CEODec 03Option Exercise0.005,4960110,059Dec 05 05:43 PM
Zulueta Alfonso GSVP & President, Lilly Int'lNov 10Sale83.672,003167,59143,580Nov 13 12:55 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale86.81205,00017,795,025123,275,804Oct 05 02:56 PM
LILLY ENDOWMENT INC10% OwnerSep 29Sale85.14195,00016,602,601123,480,804Oct 02 03:39 PM
LILLY ENDOWMENT INC10% OwnerSep 15Sale82.53190,00015,679,772123,675,804Sep 18 03:42 PM
LILLY ENDOWMENT INC10% OwnerAug 31Sale81.06180,00014,590,080123,865,804Sep 01 01:45 PM